Clinics vol.68 número5

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small- cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03..

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

In a previous study of cases of stage I non-small cell lung cancer (NSCLC), we also reported significant gender-related differences in long-term survival, with better rates

Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. American Joint Committee

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung

(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with

Other studies, using the monoclonal antibody 8F1[43] have reported that the presence of ERCC1 protein is a prognostic marker of survival in early NSCLC and a predictor of outcome